View Financial HealthThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsMedcomtech 배당 및 자사주 매입배당 기준 점검 0/6Medcomtech 현재 배당금을 지급하지 않습니다.핵심 정보0%배당 수익률0.02%자사주 매입 수익률총 주주 수익률0.02%미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향0%최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updatesNew Risk • Nov 05New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (10% average weekly change). Market cap is less than US$10m (€5.38m market cap, or US$5.76m). Minor Risk Latest financial reports are more than 6 months old (reported December 2022 fiscal period end).분석 기사 • Oct 18Returns Are Gaining Momentum At Medcomtech (BME:MED)What are the early trends we should look for to identify a stock that could multiply in value over the long term? One...분석 기사 • Aug 26Many Still Looking Away From Medcomtech, S.A. (BME:MED)Medcomtech, S.A.'s ( BME:MED ) price-to-sales (or "P/S") ratio of 0.2x may look like a pretty appealing investment...Reported Earnings • Apr 21Full year 2022 earnings releasedFull year 2022 results: Revenue: €24.9m (up 9.2% from FY 2021). Net loss: €1.59m (loss widened 22% from FY 2021).분석 기사 • Mar 21Returns At Medcomtech (BME:MED) Are On The Way UpFinding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...분석 기사 • Dec 06Medcomtech (BME:MED) Is Experiencing Growth In Returns On CapitalIf you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...Board Change • Nov 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.분석 기사 • Aug 16Investors Will Want Medcomtech's (BME:MED) Growth In ROCE To PersistTo find a multi-bagger stock, what are the underlying trends we should look for in a business? One common approach is...Board Change • Apr 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.분석 기사 • Apr 09Medcomtech (BME:MED) Is Looking To Continue Growing Its Returns On CapitalIf we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Typically, we'll...분석 기사 • May 17Here's Why Medcomtech (BME:MED) Can Afford Some DebtDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Valuation Update With 7 Day Price Move • Mar 04Investor sentiment improved over the past weekAfter last week's 20% share price gain to €1.20, the stock is trading at a trailing P/E ratio of 3.7x, up from the previous P/E ratio of 3.1x. This compares to an average P/E of 26x in the Healthcare industry in Europe. Total return to shareholders over the past three years is a loss of 64%.Is New 90 Day High Low • Feb 12New 90-day high: €0.97The company is up 32% from its price of €0.74 on 13 November 2020. The Spanish market is up 4.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Healthcare industry, which is down 1.0% over the same period.Is New 90 Day High Low • Jan 21New 90-day high: €0.78The company is up 5.0% from its price of €0.74 on 23 October 2020. The Spanish market is up 17% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Healthcare industry, which is up 9.0% over the same period.Is New 90 Day High Low • Jan 05New 90-day low: €0.56The company is down 24% from its price of €0.74 on 07 October 2020. The Spanish market is up 15% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Healthcare industry, which is up 2.0% over the same period.Is New 90 Day High Low • Dec 11New 90-day low: €0.69The company is down 4.0% from its price of €0.71 on 11 September 2020. The Spanish market is up 16% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Healthcare industry, which is flat over the same period.분석 기사 • Nov 30Should Weakness in Medcomtech, S.A.'s (BME:MED) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?With its stock down 8.3% over the past three months, it is easy to disregard Medcomtech (BME:MED). But if you pay...공지 • Jul 18Medcomtech, S.A. Auditor Raises 'Going Concern' DoubtMedcomtech, S.A. filed its Annual on Jul 06, 2020 for the period ending Dec 31, 2019. In this report its auditor, Deloitte & Touche LLP, gave a qualified opinion expressing doubt that the company can continue as a going concern.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 MED 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: MED 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장Medcomtech 배당 수익률 vs 시장MED의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (MED)0%시장 하위 25% (ES)2.0%시장 상위 25% (ES)5.2%업계 평균 (Healthcare)2.6%분석가 예측 (MED) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 MED 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 MED 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: MED Spanish 시장에서 주목할만한 배당금을 지급하지 않습니다.주주 현금 배당현금 흐름 범위: MED 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YES 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2024/04/13 17:01종가2024/01/15 00:00수익2023/06/30연간 수익2022/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Medcomtech, S.A.는 1명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Michael Thomas CooperEdison Investment Research
New Risk • Nov 05New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (10% average weekly change). Market cap is less than US$10m (€5.38m market cap, or US$5.76m). Minor Risk Latest financial reports are more than 6 months old (reported December 2022 fiscal period end).
분석 기사 • Oct 18Returns Are Gaining Momentum At Medcomtech (BME:MED)What are the early trends we should look for to identify a stock that could multiply in value over the long term? One...
분석 기사 • Aug 26Many Still Looking Away From Medcomtech, S.A. (BME:MED)Medcomtech, S.A.'s ( BME:MED ) price-to-sales (or "P/S") ratio of 0.2x may look like a pretty appealing investment...
Reported Earnings • Apr 21Full year 2022 earnings releasedFull year 2022 results: Revenue: €24.9m (up 9.2% from FY 2021). Net loss: €1.59m (loss widened 22% from FY 2021).
분석 기사 • Mar 21Returns At Medcomtech (BME:MED) Are On The Way UpFinding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
분석 기사 • Dec 06Medcomtech (BME:MED) Is Experiencing Growth In Returns On CapitalIf you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Board Change • Nov 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
분석 기사 • Aug 16Investors Will Want Medcomtech's (BME:MED) Growth In ROCE To PersistTo find a multi-bagger stock, what are the underlying trends we should look for in a business? One common approach is...
Board Change • Apr 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
분석 기사 • Apr 09Medcomtech (BME:MED) Is Looking To Continue Growing Its Returns On CapitalIf we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Typically, we'll...
분석 기사 • May 17Here's Why Medcomtech (BME:MED) Can Afford Some DebtDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Valuation Update With 7 Day Price Move • Mar 04Investor sentiment improved over the past weekAfter last week's 20% share price gain to €1.20, the stock is trading at a trailing P/E ratio of 3.7x, up from the previous P/E ratio of 3.1x. This compares to an average P/E of 26x in the Healthcare industry in Europe. Total return to shareholders over the past three years is a loss of 64%.
Is New 90 Day High Low • Feb 12New 90-day high: €0.97The company is up 32% from its price of €0.74 on 13 November 2020. The Spanish market is up 4.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Healthcare industry, which is down 1.0% over the same period.
Is New 90 Day High Low • Jan 21New 90-day high: €0.78The company is up 5.0% from its price of €0.74 on 23 October 2020. The Spanish market is up 17% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Healthcare industry, which is up 9.0% over the same period.
Is New 90 Day High Low • Jan 05New 90-day low: €0.56The company is down 24% from its price of €0.74 on 07 October 2020. The Spanish market is up 15% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Healthcare industry, which is up 2.0% over the same period.
Is New 90 Day High Low • Dec 11New 90-day low: €0.69The company is down 4.0% from its price of €0.71 on 11 September 2020. The Spanish market is up 16% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Healthcare industry, which is flat over the same period.
분석 기사 • Nov 30Should Weakness in Medcomtech, S.A.'s (BME:MED) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?With its stock down 8.3% over the past three months, it is easy to disregard Medcomtech (BME:MED). But if you pay...
공지 • Jul 18Medcomtech, S.A. Auditor Raises 'Going Concern' DoubtMedcomtech, S.A. filed its Annual on Jul 06, 2020 for the period ending Dec 31, 2019. In this report its auditor, Deloitte & Touche LLP, gave a qualified opinion expressing doubt that the company can continue as a going concern.